| Field | Specification |
|---|---|
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of DA concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Universal DA. During the reaction, Universal DA in the sample or standard competes with a fixed amount of Universal DA on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Universal DA. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Universal DA in tested samples can be calculated by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 18.75 pg/mL |
|---|---|
| Detection Range | 31.25-2000 pg/mL |
| Total Assay Time | 2 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Universal (multi-species validated) |
| Detection Method | Competitive |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Universal DA in samples.No significant cross-reactivity or interference between Universal DA and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 18.75 pg/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 2 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Competitive ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant DA standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Dual regulation of mitochondrial fusion by Parkin–PINK1 and OMA1 (2025) NATURE. 10.1038/s41586-025-08590-2
An Implant-Free Nanosystem Enabling Synergistic Oxidative Damage Mitigation and Deep Brain Stimulation for Alleviating Parkinsonian Symptoms (2025) ACS Nano. 10.1021/acsnano.5c06227
Sciatic nerve stimulation enhances NK cell cytotoxicity through dopamine signaling and synergizes immunotherapy in triple-negative breast cancer (2025) DRUG RESISTANCE UPDATES. 10.1016/j.drup.2025.101212
Inhibition of sympathetic tone via hypothalamic descending pathway propagates glucocorticoid-induced endothelial impairment and osteonecrosis of the femoral head (2024) Bone Research. 10.1038/s41413-024-00371-3
Dopamine D1 Receptor Contributes to Glucocorticoid-Associated Osteonecrosis of Femoral Head Protection Through the ATF3/CHOP Axis to Inhibit Osteoblastic Apoptosis (2025) Advanced Science. 10.1002/advs.202502276
The PM20D1-NADA pathway protects against Parkinson’s disease (2024) CELL DEATH AND DIFFERENTIATION. 10.1038/s41418-024-01356-9
Structural characteristics and potential antidepressant mechanism of a water-insoluble β-1,3-glucan from an edible fungus Wolfiporia cocos (2024) CARBOHYDRATE POLYMERS. 10.1016/j.carbpol.2024.122779
Decreased peripheral mtDNA in methamphetamine use disorder (2022) Science China-Life Sciences. 10.1007/s11427-021-2027-1
Functionalized lipid nanoparticles modulate the blood-brain barrier and eliminate α-synuclein to repair dopamine neurons (2024) Asian Journal of Pharmaceutical Sciences. 10.1016/j.ajps.2024.100904
Combination anti-PD-1 and electroacupuncture induces a potent anti-tumor immune response in microsatellite-stable colorectal cancer (2023) Cancer Immunology Research. 10.1158/2326-6066.CIR-23-0309
Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice (2022) Cell Death & Disease. 10.1038/s41419-022-04562-w
Artemisinin alleviates Parkinson’s disease by targeting Adcy5-Gch1 axis to trigger a cascade generation of BH4 and dopamine in rats (2025) GENOME BIOLOGY. 10.1186/s13059-025-03712-5
Spatial Metabolomics Combined with MALDI-MSI Unveils Gut-Brain Axis Mechanisms of Angelica dahurica Radix in Migraine Rats (2026) PHYTOMEDICINE. 10.1016/j.phymed.2026.157815
Neurobehavioral and neurochemical effects of nano-sized polypropylene accumulation in zebrafish (Danio rerio) (2025) SCIENCE OF THE TOTAL ENVIRONMENT. 10.1016/j.scitotenv.2025.179404
Prevalence of perturbed gut microbiota in pathophysiology of arsenic-induced anxiety- and depression-like behaviour in mice (2024) CHEMOSPHERE. 10.1016/j.chemosphere.2024.143293
Antidepressant effects of supercritical CO2 extract of Citri Reticulatae Pericarpium through mediating gut microbiota dysbiosis, tryptophan and bile acid metabolisms (2026) FOOD RESEARCH INTERNATIONAL. 10.1016/j.foodres.2026.118879
Inhibition of abnormal C/EBPβ/α-Syn signaling pathway through activation of Nrf2 ameliorates Parkinson's disease-like pathology (2023) AGING CELL. 10.1111/acel.13958
Mitochondrial Calcium-Triggered Oxidative Stress and Developmental Defects in Dopaminergic Neurons Differentiated from Deciduous Teeth-Derived Dental Pulp Stem Cells with MFF Insufficiency (2022) Antioxidants. 10.3390/antiox11071361
DA-DRD5 signaling reprograms B cells to promote CD8+ T?cell-mediated antitumor immunity (2025) Cell Reports. 10.1016/j.celrep.2025.115364
Radix Bupleuri aqueous extract attenuates MK801-induced schizophrenia-like symptoms in mice: Participation of intestinal flora (2024) BIOMEDICINE & PHARMACOTHERAPY. 10.1016/j.biopha.2024.116267
Apigetrin-enriched Pulmeria alba extract prevents assault of STZ on pancreatic β-cells and neuronal oxidative stress with concomitant attenuation of tissue damage and suppression of inflammation in the brain of diabetic rats (2023) BIOMEDICINE & PHARMACOTHERAPY. 10.1016/j.biopha.2023.114582
Chaihujialonggumulitang shows psycho-cardiology therapeutic effect on acute myocardial infarction with comorbid anxiety by the activation of Nrf2/HO-1 pathway and suppression of oxidative stress and apoptosis (2022) BIOMEDICINE & PHARMACOTHERAPY. 10.1016/j.biopha.2022.113437
Attenuation of hyperglycemia-associated dyslipidemic, oxidative, cognitive, and inflammatory crises via modulation of neuronal ChEs/NF-κB/COX-2/NOx, and?hepatorenal functional deficits by the Tridax procumbens extract (2022) BIOMEDICINE & PHARMACOTHERAPY. 10.1016/j.biopha.2022.114114
Research on the mechanism of probiotics regulating gut microbiota to alleviate cadmium immunotoxicity in juvenile Pardosa pseudoannulata (2025) Environmental Technology & Innovation. 10.1016/j.eti.2025.104628
Galanin(1?15) and Naltrexone: A novel approach for alcohol use disorder in rats, involving the mesolimbic system (2025) BIOMEDICINE & PHARMACOTHERAPY. 10.1016/j.biopha.2025.118170
